ASXC) is a penny stock that may appeal to speculators. With a market capitalization of under $70 million, ASXC is not for the faint of heart. The company’s augmented intelligence technology and the total addressable market for minimally invasive surgical instruments, projected to reach $63 billion by 2030, make it an attractive option for those who believe in the narrative. Incurring top-line erosion and net losses, ASXC could be one of the medical robotics stocks to consider for potential market returns.\n\nMedical robotics stocks offer a risky but viable path to significant market returns, with experts projecting impressive growth in the sector.”
“Medical Robotics Stocks: A Risky but Viable Path to Significant Market Returns\n\nMedical robotics stocks have been gaining attention in the post-pandemic period, with experts projecting significant growth in the sector. According to Grand View Research, the global medical robotic systems market size is expected to reach $76.4 billion by 2030, translating to a compound annual growth rate of 16.9%. While projections may not always pan out, the consensus range among experts is still promising. This makes medical robotics stocks a risky but viable path to significant market returns.\n\nGlobus Medical (GMED): A Compelling Choice for Investors\n\nPennsylvania-based Globus Medical (NYSE:GMED) is one of the most compelling medical robotics stocks in the market. The company focuses on developing products that enable surgeons to promote healing in patients with musculoskeletal disorders. While GMED has seen a 38% decline in equity value since the beginning of the year, it still enjoys a massive total addressable market. According to Allied Market Research, the global musculoskeletal disorders drugs market size is expected to reach $126 billion by 2032, with the rehabilitation robotics subsegment projected to hit $1 billion by 2030. Not having the most stellar financials, Globus has shown solid growth on the top line, making it a potential choice for investors.\n\nAsensus Surgical (ASXC): A High-Risk, High-Reward Option\n\nFor those willing to take on extreme risk for the possibility of extreme rewards, Asensus Surgical (NYSEAMERICAN:ASXC) is a penny stock that may appeal to speculators. With a market capitalization of under $70 million, ASXC is not for the faint of heart. The company’s augmented intelligence technology and the total addressable market for minimally invasive surgical instruments, projected to reach $63 billion by 2030, make it an attractive option for those who believe in the narrative. Incurring top-line erosion and net losses, ASXC could be one of the medical robotics stocks to consider for potential market returns.\n\nMedical robotics stocks offer a risky but viable path to significant market returns, with experts projecting impressive growth in the sector.”$MBOT2023-12-29T10:20:46.183Z
